Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Revance Therapeutics, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agorevance.com
Revance Therapeutics, Inc., commonly known as Revance, is a prominent US-based biopharmaceutical company. Established in 2002, this pharmaceutical preparation manufacturer specialises in advancing innovative aesthetic and therapeutic solutions.
Leveraging its proprietary peptide technology platform, Revance is renowned for developing differentiated neuromodulators and premium dermal fillers. Their flagship product, DAXXIFY® (DaxibotulinumtoxinA-lanm), represents the first novel neuromodulator in decades, offering a longer-lasting effect for aesthetic indications and therapeutic treatment for cervical dystonia. Complementing this, the RHA® Collection of dermal fillers provides natural-looking results designed for dynamic facial expression.
With a focus on redefining patient and practitioner experiences, Revance continues to solidify its market position as an innovator in the medical aesthetics and therapeutics sectors. The company is committed to delivering groundbreaking treatments that address unmet needs within these fields.
23
DitchCarbon score
-19 vs industry average
Revance Therapeutics, Inc.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Revance Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Revance Therapeutics, Inc. yet.
Revance Therapeutics, Inc.'s reported carbon emissions
Revance Therapeutics, Inc., a US-based pharmaceutical preparation manufacturing company, does not publicly report its carbon emissions data. Therefore, specific figures for Scope 1, Scope 2, or Scope 3 emissions cannot be provided. The company has no stated reduction targets or climate commitments, including participation in initiatives like the Science Based Targets initiative (SBTi) or the Climate Pledge. However, the available data indicates that Revance Therapeutics, Inc. itself is the source organisation for any potential CDP reporting, and it does not inherit performance data from a parent entity.
Assessing Revance Therapeutics, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Revance Therapeutics, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Revance Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Revance Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Revance Therapeutics, Inc.10 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more